The global market for non-corticosteroid anti-inflammatory eyedrops was substantial in 2020 and is expected to see a significant growth rate throughout the forecast period. This growth is being propelled by the increasing prevalence of cystoid macular edema (CME) worldwide and the rising demand to enhance visual clarity after cataract surgery in patients with minimal risk factors.
The use of non-corticosteroid anti-inflammatory drugs has shown remarkable efficacy in reducing CME, as diagnosed by optical coherence tomography (OCT) or angiography. Moreover, these drugs expedite the recovery of vision post eye surgery. Their effectiveness exceeds that of both placebos and corticosteroid formulations that have limited penetration into the eye. This aspect significantly contributes to the revenue surge in the global market for non-corticosteroid anti-inflammatory eyedrops.
These medications have become indispensable for surgeons conducting routine and intricate cataract surgeries. They aid in pain management, prevent intraoperative miosis, handle postoperative inflammation, and decrease the occurrence of CME. Whether used independently or for eyes at high risk of CME, their efficacy is noteworthy. Furthermore, their application around the time of surgery markedly enhances post-surgical outcomes and reduces the likelihood of CME in patients at low risk.
Manufacturers in the market are collaborating with pharmaceutical industry partners to introduce their unique formulations of non-corticosteroid anti-inflammatory eyedrops. This strategy enhances their distinct selling points (USPs), impacting the overall growth in revenue and market size of non-corticosteroid anti-inflammatory eyedrops.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/400
Companies considered and profiled in this market study
Some of the leading players in the non corticosteroid anti-inflammatory eyedrops market include Novartis AG, Alcon, Bausch & Lomb Inc, Allergan, Inc., Visine, Meda Pharmaceuticals Inc, Bausch & Lomb, Similasan Corporation, Cigna, Viva Opti-Free, Clear eyes, Systane, Staples, Rite Aid, and Walgreens.
Major companies are adopting various strategies, including mergers, acquisitions, partnerships, and new product development, among others to stay ahead of the competition and expand market footprint and revenue share.
Factors Affecting of Non Corticosteroid Anti-inflammatory Eyedrops Market
1. Medical Conditions: Conditions like dry eye syndrome, conjunctivitis, uveitis, and post-operative inflammation drive the demand for anti-inflammatory eyedrops.
2. Technological Advancements: Innovations in drug delivery systems or formulations can affect the market by improving efficacy, reducing side effects, or enhancing convenience of use.
3. Regulatory Environment: Changes in regulations regarding the approval, manufacturing, or marketing of these eyedrops can significantly impact their availability and market growth.
4. Competition: Introduction of new products or generic versions of existing medications can affect market share and pricing.
5. Consumer Awareness and Education: Awareness campaigns and educational efforts about eye health and the availability of non-corticosteroid anti-inflammatory eyedrops can influence consumer choices.
6. Demographics: Ageing populations and increasing incidence of eye-related disorders among certain demographics can drive market growth.
7. Economic Factors: Affordability, insurance coverage, and healthcare expenditure influence the accessibility and affordability of these medications.
8. Global Health Factors: Pandemics or health crises, such as the COVID-19 pandemic, can impact healthcare systems, affecting both supply chains and patient access to medications.
9. Research and Development: Ongoing research leading to the development of more effective or novel non-corticosteroid anti-inflammatory eyedrops can significantly impact the market.
10.Physician Preferences: Prescribing patterns and preferences of healthcare providers can influence the adoption and usage of specific medications within this category.
These factors collectively shape the demand, supply, and overall landscape of the non-corticosteroid anti-inflammatory eyedrops market.
To know more about the report @ https://www.reportsanddata.com/report-detail/non-corticosteroid-anti-inflammatory-eyedrops-market
For the purpose of this report, Reports and Data has segmented the global non corticosteroid anti-inflammatory eyedrops market on the basis of type, application, and region:
Type Outlook (Revenue, USD Billion, 2018 - 2028)
- Ocufen
- Mugabe
- Diclofenac
- Others
Application Outlook (Revenue, USD Billion, 2018 – 2028)
- Adult
- Children
Regional Outlook (Revenue, USD Billion, 2018 - 2028)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- MEA
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/400
Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
Browse Upcoming Reports: https://www.reportsanddata.com/upcoming-reports
